PS Ratio Chart

View PS Ratio for ECOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2018. Start Trial.
Date Value
September 08, 2026 2.137
September 04, 2026 2.168
September 03, 2026 2.168
September 02, 2026 2.239
September 01, 2026 2.130
August 31, 2026 2.234
August 28, 2026 2.266
August 27, 2026 2.286
August 26, 2026 2.436
August 25, 2026 2.229
August 24, 2026 2.272
August 21, 2026 2.476
August 20, 2026 2.403
August 19, 2026 2.545
August 18, 2026 2.418
August 17, 2026 2.413
August 14, 2026 2.347
August 13, 2026 2.340
August 12, 2026 2.213
August 11, 2026 2.147
August 10, 2026 2.109
August 07, 2026 1.904
August 06, 2026 1.577
August 05, 2026 1.537
August 04, 2026 1.466
Date Value
August 03, 2026 1.434
July 31, 2026 1.432
July 30, 2026 1.481
July 29, 2026 1.429
July 28, 2026 1.434
July 27, 2026 1.424
July 24, 2026 1.457
July 23, 2026 1.498
July 22, 2026 1.49
July 21, 2026 1.506
July 20, 2026 1.429
July 17, 2026 1.384
July 16, 2026 1.361
July 15, 2026 1.419
July 14, 2026 1.448
July 13, 2026 1.535
July 10, 2026 1.552
July 09, 2026 1.563
July 08, 2026 1.537
July 07, 2026 1.862
July 06, 2026 1.949
July 02, 2026 2.064
July 01, 2026 1.954
June 30, 2026 2.034
June 29, 2026 1.961

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Myomo, Inc. 1.311
Accuray, Inc. 0.0763
Micron Solutions, Inc. --
Orthofix Medical, Inc. 0.4313
ResMed, Inc. 5.682

PS Ratio Related Metrics

Price 9.00
Earnings Yield -18.85%
Market Cap 81.01M